One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
Price : 100$- Special Price : 50$
Using Genetic Risk Scores for Rheumatoid Arthritis–Associated Interstitial Lung Disease Risk Stratification
doi : 10.1002/acr.80003
Validation of a Genetic Risk Score Combined With Clinical Variables for Predicting Pulmonary Fibrosis in Early Rheumatoid Arthritis
doi : 10.1002/acr.25696
Mortality in US Veterans With Rheumatoid Arthritis Treated With Immune Checkpoint Inhibitors
doi : 10.1002/acr.25691
Objectively Measured Sleep Disorders in Rheumatoid Arthritis and Their Association With Disease Activity
doi : 10.1002/acr.25685
The Renal Activity Index for Lupus Identifies Active Renal Disease and Treatment Response in Adult Patients With Systemic Lupus Erythematosus and Lupus Nephritis
doi : 10.1002/acr.25684
Role of Prednisone and 25-Hydroxyvitamin D on Bone Mineral Density and Osteoporosis in Systemic Lupus Erythematosus
doi : 10.1002/acr.25701
Sarilumab in Polyarticular-Course Juvenile Idiopathic Arthritis: Dose-Finding and 1-Year Analysis of a Phase 2b, Open-Label, Multicenter Study
doi : 10.1002/acr.25692
Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Belimumab in Pediatric Patients With Systemic Lupus Erythematosus: A Multicenter, Open-Label Trial
doi : 10.1002/acr.25700
Preferences for Posttraumatic Osteoarthritis Prevention Strategies in Individuals With Anterior Cruciate Ligament Injury
doi : 10.1002/acr.25641
Response to Allopurinol and Febuxostat According to the Fractional Excretion of Urate in Men With Gout
doi : 10.1002/acr.25695
Advances in Synovial Fluid Analysis for the Diagnosis of Crystal Arthropathies
doi : 10.1002/acr.25698
Performance Characteristics of Anti–Collagen II Antibodies in Relapsing Polychondritis and Related Diseases: Prospective Analysis, Systematic Review, and Meta-Analysis
doi : 10.1002/acr.25697
Bridging clinical relevance and equity in the cost-effectiveness of standardized exercise therapy for osteoarthritis: comment on the article by Mazzei et al
doi : 10.1002/acr.25688
